Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ebola convalescent plasma study
PACTR201602001355272Phase 2Recruiting
- Sponsor
- University of Liverpool
- Start
- Feb 2015
- Countries
- 1
01
Overview
Phase 2, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in Ebola virus disease (EVD) (2 arms), sponsored by University of Liverpool. Primary endpoint: All-cause mortality. Started Feb 2015; status: recruiting.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on PACTR201602001355272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201602001355272.